Wenancjusz Domagala

Wenancjusz Domagala

Pomeranian Medical University - Szczecin / Poland
Others
AD Scientific Index ID: 1872835
Pomeranian Medical University in Szczecin
person_outline Wenancjusz Domagala's MOST POPULAR ARTICLES
1-) Vimentin is preferentially expressed in human breast carcinomas with low estrogen receptor and high Ki-67 growth fraction.W Domagala, J Lasota, J Bartkowiak, K Weber, M OsbornThe American journal of pathology 136 (1), 219, 19901591990
2-) PARP-1 expression in breast cancer including BRCA1-associated, triple negative and basal-like tumors: possible implications for PARP-1 inhibitor therapyP Domagala, T Huzarski, J Lubinski, K Gugala, W DomagalaBreast cancer research and treatment 127, 861-869, 20111352011
3-) Value of pedigree/clinical data, immunohistochemistry and microsatellite instability analyses in reducing the cost of determining hMLH1 and hMSH2 gene mutations in patients …T Debniak, G Kurzawski, B Gorski, J Kladny, W Domagala, J LubinskiEuropean Journal of Cancer 36 (1), 49-54, 20001382000
4-) The NOD2 3020insC Mutation and the Risk of Colorectal CancerG Kurzawski, J Suchy, J Kładny, E Grabowska, M Mierzejewski, ...Cancer Research 64 (5), 1604-1606, 20041372004
5-) Vimentin expression appears to be associated with poor prognosis in node-negative ductal NOS breast carcinomas.W Domagala, J Lasota, A Dukowicz, M Markiewski, G Striker, K Weber, ...The American journal of pathology 137 (6), 1299, 19901261990